CVS Health Corp
Held by 23 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 126650100 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 23 of the investors we track own this stock. In the latest quarter, 10 of them bought more of it and 13 sold some or all of theirs (3 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
23
+1 vs last quarter (like-for-like)
Total value held
$12.85B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
1.6%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$3.21B
+41.3% vs last quarter
Net shares bought
-2.0M
Est. net flow -$120.29M
Quarter activity
10 bought · 13 sold
3 new · 2 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns CVS?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns CVS? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↑ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 23 | Beutel Goodman | Beutel, Goodman & Co | 600 | $62.00K | 0.0% | Reduced | -5.3K | -89.8% | -$544.05K |
| 22 | Fred Alger | Fred Alger Management | 26.48K | $2.74M | 0.0% | New | +26.5K | — | +$2.74M |
| 21 | Ken Fisher | Fisher Asset Management | 92.01K | $9.52M | 0.0% | Added | +3.6K | +4.1% | +$374.28K |
| 20 | Mario Gabelli | GAMCO Investors | 93.72K | $9.70M | 0.1% | Added | +498 | +0.5% | +$51.52K |
| 19 | Bill Nygren | Harris Associates (Oakmark Funds) | 335.82K | $34.74M | 0.0% | Reduced | -158.3K | -32.0% | -$16.38M |
| 18 | Ray Dalio | Bridgewater Associates | 440.97K | $45.62M | 0.2% | Reduced | -177.5K | -28.7% | -$18.36M |
| 17 | Jim Simons | Renaissance Technologies | 441.02K | $45.62M | 0.1% | Added | +177.9K | +67.6% | +$18.40M |
| 16 | Jeremy Grantham | GMO | 541.12K | $55.98M | 0.1% | Reduced | -93.7K | -14.8% | -$9.70M |
| 15 | John Rogers | Ariel Investments | 730.11K | $75.53M | 0.8% | Added | +28.0K | +4.0% | +$2.89M |
| 14 | David Shaw | D.E. Shaw & Co. | 1.38M | $142.97M | 0.1% | Reduced | -235.5K | -14.6% | -$24.36M |
| 13 | Charles Brandes | Brandes Investment Partners | 1.67M | $173.21M | 1.2% | Reduced | -295.5K | -15.0% | -$30.57M |
| 12 | Steve Cohen | Point72 Asset Management | 1.96M | $202.87M | 0.3% | New | +2.0M | — | +$202.87M |
| 11 | Boston Partners | Boston Partners Global Investors | 2.03M | $210.37M | 0.2% | Added | +1.9M | +1783.4% | +$199.20M |
| 10 | Israel Englander | Millennium Management | 2.16M | $223.95M | 0.2% | Added | +2.0M | +1013.6% | +$203.84M |
| 9 | Prem Watsa | Fairfax Financial Holdings | 2.71M | $280.50M | 10.6% | Held | 0 | 0.0% | $0 |
| 8 | Andreas Halvorsen | Viking Global Investors | 3.66M | $378.97M | 1.1% | New | +3.7M | — | +$378.97M |
| 7 | LSV Asset Management | LSV Asset Management | 4.64M | $479.52M | 0.9% | Added | +131.8K | +2.9% | +$13.63M |
| 6 | Ken Griffin | Citadel Advisors | 4.81M | $497.86M | 0.3% | Reduced | -615.5K | -11.3% | -$63.67M |
| 5 | Larry Robbins | Glenview Capital | 4.82M | $499.13M | 10.0% | Reduced | -3.4M | -41.1% | -$348.83M |
| 4 | Richard Pzena | Pzena Investment Management | 11.77M | $1.22B | 3.6% | Reduced | -2.0M | -14.5% | -$207.26M |
| 3 | Chris Davis | Davis Selected Advisers | 11.87M | $1.23B | 5.3% | Reduced | -373.8K | -3.1% | -$38.67M |
| 2 | Norges Bank | Norges Bank Investment Management | 18.04M | $1.87B | 0.2% | — | — | — | — |
| 1 | Dodge & Cox | Dodge & Cox | 50.01M | $5.17B | 2.7% | Reduced | -1.8M | -3.4% | -$182.83M |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Hotchkis & Wiley | Hotchkis & Wiley Capital Management | -2.8M | $200.72M |
| Tweedy, Browne & Co | Tweedy, Browne Company LLC | -19.1K | $1.37M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lisa McClain Politician | Oct 30, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 31, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 21 days | PTR ↗ |
| Michael T. McCaul Politician | Sep 5, 2025 | CVS | CVS HEALTH CORP 7 scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | — | — | Sep 11, 2025 | 6 days | PTR ↗ |
| Michael T. McCaul Politician | Jul 5, 2025 | CVS | CVS HEALTH CORP a scanned | Sale | $50,001 - $100,000 | Est. $75,000 (midpoint of reported range $50,001–$100,000) | Spouse | — | Jul 7, 2025 | 2 days | PTR ↗ |
| Jefferson Shreve Politician | May 12, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | CRT - Standard Unit Trust | Jun 22, 2025 | 41 days | PTR ↗ |
| Robert P. Bresnahan, Jr. Politician | May 15, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | JP Morgan Brokerage Account | May 31, 2025 | 16 days | PTR ↗ |
| Robert P. Bresnahan, Jr. Politician | Feb 25, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | JP Morgan Brokerage Account | Mar 27, 2025 | 30 days | PTR ↗ |
| J. French Hill Politician | Jan 31, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | HILL FAMILY FUND | Feb 4, 2025 | 4 days | PTR ↗ |
| Michael T. McCaul Politician | Jan 5, 2025 | CVS | CVS HEALTH CORP scanned | Sale | $50,001 - $100,000 | Est. $75,000 (midpoint of reported range $50,001–$100,000) | — | — | Jan 15, 2025 | 10 days | PTR ↗ |
| Michael T. McCaul Politician | Jan 5, 2025 | CVS | CVS HEALTH CORP scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jan 15, 2025 | 10 days | PTR ↗ |
| Michael T. McCaul Politician | Jul 5, 2024 | CVS | CVS HEALTH CORP scanned | Purchase | — | — | — | — | Jul 22, 2024 | 17 days | PTR ↗ |